Evaluation of SDHB, SDHD and VHL gene susceptibility testing in the assessment of individuals with non-syndromic phaeochromocytoma, paraganglioma and head and neck paraganglioma, Clinical Endocrinology, vol.31, issue.6, pp.898-906, 2013. ,
DOI : 10.1002/humu.21269
Head and neck paragangliomas: genetic spectrum and clinical variability in 79 consecutive patients, Endocrine Related Cancer, vol.19, issue.2, pp.149-155, 2012. ,
DOI : 10.1530/ERC-11-0369
URL : http://erc.endocrinology-journals.org/content/19/2/149.full.pdf
Clinical aspects of SDHx-related pheochromocytoma and paraganglioma, Endocrine Related Cancer, vol.16, issue.2, pp.391-400, 2009. ,
DOI : 10.1677/ERC-08-0284
Treatment of malignant pheochromocytoma/paraganglioma with cyclophosphamide, vincristine, and dacarbazine, Cancer, vol.24, issue.8, pp.2020-2028, 2008. ,
DOI : 10.1007/BF03345807
HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: Novel role of fumarate in regulation of HIF stability, Cancer Cell, vol.8, issue.2, pp.143-153, 2005. ,
DOI : 10.1016/j.ccr.2005.06.017
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate, Nature, vol.50, issue.7274, pp.739-744, 2009. ,
DOI : 10.1038/nature08617
Influence of Metabolism on Epigenetics and Disease, Cell, vol.153, issue.1, pp.56-69, 2013. ,
DOI : 10.1016/j.cell.2013.03.004
SDH Mutations Establish a Hypermethylator Phenotype in Paraganglioma, Cancer Cell, vol.23, issue.6, pp.739-752, 2013. ,
DOI : 10.1016/j.ccr.2013.04.018
Accumulation of Krebs cycle intermediates and over-expression of HIF1?? in tumours which result from germline FH and SDH mutations, Human Molecular Genetics, vol.14, issue.15, pp.2231-2239, 2005. ,
DOI : 10.1042/bj20031647
Inhibition of ??-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors, Genes & Development, vol.26, issue.12, pp.1326-1338, 2012. ,
DOI : 10.1101/gad.191056.112
Exploring the Human Metabolome by Nuclear Magnetic Resonance Spectroscopy and Mass Spectrometry, 2013. ,
DOI : 10.1017/CBO9780511996634.002
Non-invasive detection of 2-hydroxyglutarate and other metabolites in IDH1 mutant glioma patients using magnetic resonance spectroscopy, Journal of Neuro-Oncology, vol.19, issue.1, pp.197-205, 2012. ,
DOI : 10.1016/j.ccr.2010.12.014
Reproducible Sample Preparation and Spectrum Acquisition Techniques for Metabolic Profiling of Human Tissues by Proton High-Resolution Magic Angle Spinning Nuclear Magnetic Resonance, 2013. ,
DOI : 10.1017/CBO9780511996634.027
Modified Spin???Echo Method for Measuring Nuclear Relaxation Times, Review of Scientific Instruments, vol.233, issue.8, pp.688-691, 1958. ,
DOI : 10.1103/RevModPhys.26.167
1H and13C HR-MAS spectroscopy of intact biopsy samplesex vivo andin vivo1H MRS study of human high grade gliomas, NMR in Biomedicine, vol.17, issue.4, pp.191-205, 2004. ,
DOI : 10.1002/nbm.888
HMDB: the Human Metabolome Database, Nucleic Acids Research, vol.35, issue.Database, pp.521-526, 2007. ,
DOI : 10.1093/nar/gkl923
URL : https://academic.oup.com/nar/article-pdf/35/suppl_1/D521/3870909/gkl923.pdf
Genotype-Specific Abnormalities in Mitochondrial Function Associate with Distinct Profiles of Energy Metabolism and Catecholamine Content in Pheochromocytoma and Paraganglioma, Clinical Cancer Research, vol.19, issue.14, pp.3787-3795, 2013. ,
DOI : 10.1158/1078-0432.CCR-12-3922
High-resolution magic-angle-spinning NMR spectroscopy for metabolic profiling of intact tissues, Nature Protocols, vol.112, issue.6, pp.1019-1032, 2010. ,
DOI : 10.1111/j.1471-4159.1981.tb01608.x
High-resolution magic angle spinning (HR MAS) MR spectroscopy in metabolic characterization of human cancer, Progress in Nuclear Magnetic Resonance Spectroscopy, vol.54, issue.3-4, pp.239-254, 2009. ,
DOI : 10.1016/j.pnmrs.2008.10.001
Bioinformatic methods in NMR-based metabolic profiling, Progress in Nuclear Magnetic Resonance Spectroscopy, vol.55, issue.4, pp.361-374, 2009. ,
DOI : 10.1016/j.pnmrs.2009.07.003
Cross-Validation of Regression Models, Journal of the American Statistical Association, vol.9, issue.387, pp.575-583, 1984. ,
DOI : 10.1080/00401706.1977.10489581
Monte Carlo cross validation, Chemometrics and Intelligent Laboratory Systems, vol.56, issue.1, pp.1-11, 2001. ,
DOI : 10.1016/S0169-7439(00)00122-2
HMDB 3.0???The Human Metabolome Database in 2013, Nucleic Acids Research, vol.8, issue.D1, pp.801-807, 2013. ,
DOI : 10.1002/pmic.200890049
URL : https://academic.oup.com/nar/article-pdf/35/suppl_1/D521/3870909/gkl923.pdf
Metabolomic profile of the adrenal gland: from physiology to pathological conditions, Endocrine Related Cancer, vol.20, issue.5, pp.705-716, 2013. ,
DOI : 10.1530/ERC-13-0232
The Warburg Effect Is Genetically Determined in Inherited Pheochromocytomas, PLoS ONE, vol.4, issue.9, p.7094, 2009. ,
DOI : 10.1371/journal.pone.0007094.t003
Alterations of respiratory chain complexes in sporadic pheochromocytoma, Frontiers in bioscience, vol.3, pp.194-200, 2011. ,
Profiling the effects of isocitrate dehydrogenase 1 and 2 mutations on the cellular metabolome, Proceedings of the National Academy of Sciences, vol.16, issue.1, pp.3270-3275, 2011. ,
DOI : 10.1046/j.1460-9568.2002.02055.x
An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis, The Lancet Oncology, vol.10, issue.8, pp.764-771, 2009. ,
DOI : 10.1016/S1470-2045(09)70164-0
Immunohistochemistry for SDHB triages genetic testing of SDHB, SDHC, and SDHD in paraganglioma-pheochromocytoma syndromes, Human Pathology, vol.41, issue.6, pp.805-814, 2010. ,
DOI : 10.1016/j.humpath.2009.12.005
Gene Mutations in Apparently Sporadic Paragangliomas and Pheochromocytomas, The Journal of Clinical Endocrinology & Metabolism, vol.96, issue.9, pp.1472-1476, 2011. ,
DOI : 10.1210/jc.2011-1043
URL : https://academic.oup.com/jcem/article-pdf/96/9/E1472/10412793/jcem1472.pdf
Plasma Normetanephrine and Metanephrine for Detecting Pheochromocytoma in von Hippel???Lindau Disease and Multiple Endocrine Neoplasia Type 2, New England Journal of Medicine, vol.340, issue.24, pp.1872-1879, 1999. ,
DOI : 10.1056/NEJM199906173402404
Catecholamine metabolomic and secretory phenotypes in phaeochromocytoma, Endocrine Related Cancer, vol.18, issue.1, pp.97-111, 2011. ,
DOI : 10.1677/ERC-10-0211
URL : http://erc.endocrinology-journals.org/content/18/1/97.full.pdf
Pheochromocytomas in von Hippel-Lindau Syndrome and Multiple Endocrine Neoplasia Type 2 Display Distinct Biochemical and Clinical Phenotypes, The Journal of Clinical Endocrinology & Metabolism, vol.86, issue.5, pp.1999-2008, 2001. ,
DOI : 10.1210/jcem.86.5.7496
MAX Mutations Cause Hereditary and Sporadic Pheochromocytoma and Paraganglioma, Clinical Cancer Research, vol.18, issue.10, pp.2828-2837, 2012. ,
DOI : 10.1158/1078-0432.CCR-12-0160
URL : https://hal.archives-ouvertes.fr/hal-01048691
Succinate: A New Epigenetic Hacker, Cancer Cell, vol.23, issue.6, pp.709-711, 2013. ,
DOI : 10.1016/j.ccr.2013.05.015
URL : https://doi.org/10.1016/j.ccr.2013.05.015
Epigenetic links to the web of Krebs, Nature Reviews Cancer, vol.3, issue.7, p.437, 2013. ,
DOI : 10.1158/2159-8290.CD-13-0092